Search Results 261-270 of 17262 for egfr

1. Primary Sclerosing Cholangitis (PSC) Clinical Trials - Mayo Clinic Research

   Erlotinib (Tarceva) is a human EGFR type 1 tyrosine kinase inhibitor and offers greater survival benefit to EGFR positive patients. This study will assist ...

2. A Study Of EMG Vs AMG In Robotic/Laparoscopic Surgery - Mayo Clinic

   Patients with chronic kidney disease (eGFR <60). Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 12/22/2025 ...

3. A Study To Assess Efficacy And Safety Of Baxdrostat In Participants With Primary Aldosteronism - Mayo Clinic

   * eGFR ≥ 45 mL/min/1.73m2 at Screening * Serum potassium level ≥ 3.0 and \< 5.0 mmol/L at Screeningdetermined as per the central laboratory. * Have a ...

4. A Study To Evaluate The Effectiveness Of Nicotinamide Riboside And Pterostilbene Treatment To Protect The Kidneys In Patients With Complex Aortic Aneurysm Repair And Aortic Arch Reconstruction - Mayo Clinic

   Renal failure defined as eGFR< 15 mL/min/1.73m2. Patients in permanent Renal Replacement Therapy. Patients with chronic liver disease: Child-Pugh score ...

5. A Study to Evaluate Regorafenib with Cetuximab or Panitumumab to Treat Unresectable, Locally Advanced, or Metastatic Colorectal Cancer - Mayo Clinic

   The purpose of this study is to determine how well regorafenib and anti-EGFR therapy (cetuximab or panitumumab) works for the treatment of patients with ...

6. Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants with Chronic Cough - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m2 at Screening OR eGFR ≥30 mL/min/1.73 m2 and <50 mL/min/1.73 m2 at Screening with unstable ...

7. Additional Delayed-Phase Scan With PCD-CT To Improve Radiologist Confidence For The Presence Of Peritoneal Disease - Mayo Clinic

   Patients whose eGFR ≥ 30 (13,14). Allergy or previous intravenous contrast reaction. Patients with known primary mucinous or cystic neoplasms or ...

8. ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System - Mayo Clinic

   ... (eGFR) \< 25ml/min/1.73 m2 by CKD-Epi equation; or currently requiring dialysis * Performance of the six-minute walk test (6MWT) with a distance \< 50m OR ...

9. Study of Pembrolizumab With Ipilimumab or Placebo in Participants with Untreated Metastatic Non-small Cell Lung Cancer - Mayo Clinic

   Tumor harbors an EGFR-sensitizing (activating) mutation or an ALK translocation. Note: EGFR-sensitizing mutations are those mutations that are amenable to ...

10. Martin E. Fernandez-Zapico, M.D. - Mayo Clinic Faculty Profiles

    Fernandez-Zapico's research group had identified a novel molecular interaction between the Hedgehog and EGFR oncogenic pathways in pancreatic cancer that ...